Skip to main content
Equibles

MORGAN STANLEY

Position in TRAW — Traws Pharma, Inc.

CIK 895421 NEW YORK, NY
Back to TRAW Full portfolio

Position in TRAW

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$392
-$6,432 QoQ
Shares Held
468
-87.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 34 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRAW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. TRAW ranks #480 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in TRAW

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $392 468
2026-03-31 $6,824 3,729
2025-09-30 $1,330 719
2025-06-30 $1,064 719
2025-03-31 $1,666 725
2024-12-31 $139,637 15,725
2024-09-30 $4,285 729
2024-06-30 $8,214 18,255
2024-03-31 $19,042 18,855
2023-12-31 $14,140 18,855
2023-09-30 $14,277 20,110
2023-06-30 $23,728 20,110
2023-03-31 $7,928 10,862
2022-12-31 $7,059 10,862
2022-09-30 $9,557 10,862
2022-06-30 $20,937 15,862
2022-03-31 $31,202 16,958
2021-12-31 $41,577 16,305
2021-09-30 $177,355 46,307
2021-06-30 $740,026 106,786